PR Newswire - FDA Grants Orphan Drug Designation to 7MW3711...
SHANGHAI, July 16, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its self-developed novel B7-H3-targeting ADC (R&a...
Read More

ภาษาไทย
English